Market Overview

US Stock Futures Up; J.P. Morgan Earnings In Focus

US Stock Futures Up; J.P. Morgan Earnings In Focus
Related JPM
Former Wells Fargo CEO Calls Bitcoin A Pyramid Scheme
Expected Winners And Losers For Q4 Earnings Season
Bouchey Financial Group Ltd Buys iShares New York Muni Bond, Facebook Inc, JPMorgan Chase, ... (GuruFocus)
Related WFC
Visible Alpha, A Benzinga Fintech Award Alumni, Announces $38 Million Funding Round
Former Wells Fargo CEO Calls Bitcoin A Pyramid Scheme
Building Credibility And Value Still A Work In Progress For Citigroup (Seeking Alpha)

Pre-open movers

US stock futures rose in early pre-market trade, ahead of earnings from J.P. Morgan Chase & Co (NYSE: JPM) and Wells Fargo & Co (NYSE: WFC). Futures for the Dow Jones Industrial Average surged 20 points to 15,053.00, while the Standard & Poor's 500 index futures rose 1.30 points to 1,686.30. Futures for the Nasdaq 100 index gained 4.25 points to 3,197.75.

A Peek Into Global Markets

European markets were mostly higher today, with the Spanish Ibex Index falling 0.27%, London's FTSE 100 index gaining 0.73% and STOXX Europe 600 Index rising 0.32%. German DAX 30 index rose 0.30% and French CAC 40 Index surged 0.03%.

Asian markets ended higher today. Japan's Nikkei Stock Average rose 1.48%, China's Shanghai Composite climbed 1.70% and Australia's ASX/S&P500 gained 1.61%. Hong Kong's Hang Seng Index rose 1.16% and India's Sensex surged 1.26%.

Broker Recommendation

Analysts at Goldman Sachs upgraded Johnson & Johnson (NYSE: JNJ) from “sell” to “neutral.” The target price for Johnson & Johnson has been raised from $87 to $95.

Johnson & Johnson's shares closed at $87.78 yesterday.

Breaking news

  • China Lodging Group (NASDAQ: HTHT) today announced that the Company, through one of its subsidiaries, entered into a purchase agreement to acquire ordinary shares of China Quanjude (Group) Co through a private placement of RMB100 million (approximately US$16.3 million), effective upon meeting certain closing conditions. To read the full news, click here.
  • ImmunoGen (NASDAQ: IMGN) today announced that Novartis (NYSE: NVS) has licensed the exclusive right to use the Company's ADC technology to develop anticancer therapeutics to an undisclosed target. To read the full news, click here.
  • Aon Hewitt, the global talent, retirement and health solutions business of Aon plc (NYSE: AON), has announced that it advised the trustees of the Kodak Pension Plan (KPP) on its agreement to set up a new pension scheme for its members. To read the full news, click here.
  • Envestnet (NYSE: ENV) announced Thursday the pricing of a public offering on behalf of selling stockholders of 5,045,215 shares of common stock at a public offering price of $29.25 per share. To read the full news, click here.

Posted-In: US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets


Related Articles (AON + ENV)

View Comments and Join the Discussion!